Bruker Corporation to Present at Investor Conferences

Rhea-AI Summary

Bruker Corporation (Nasdaq: BRKR) announced its participation in three upcoming virtual healthcare conferences. The events include the BofA Securities 2021 Health Care Conference on May 11, 2021, the UBS Global Healthcare Virtual Conference on May 24, 2021, and the Jefferies Virtual Healthcare Conference on June 2, 2021. Key executives, including Frank Laukien and Mark Munch, will present. Live webcasts and replays will be accessible on the Investor Relations section of Bruker's website for 30 days post-event.

Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the following virtual conferences:

BofA Securities 2021 Health Care Conference
Tuesday, May 11, 2021, at 11:00 a.m. Eastern Time
Frank Laukien, Chairman, President and Chief Executive Officer
Mark Munch, President, Bruker Nano Group

UBS Global Healthcare Virtual Conference
Monday, May 24, 2021, at 9:00 a.m. Eastern Time
Frank Laukien, Chairman, President and Chief Executive Officer
Mark Munch, President, Bruker Nano Group

Jefferies Virtual Healthcare Conference
Wednesday, June 2, 2021, at 8:00 a.m. Eastern Time
Frank Laukien, Chairman, President and Chief Executive Officer
Juergen Srega, President, Bruker CALID Group

Live audio webcasts of the virtual presentation and “fireside” sessions will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. Replays will be posted on Bruker’s Investor Relations website after each event and will be available for 30 days following the presentation.

About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210507005145/en/

FAQ

When is the BofA Securities 2021 Health Care Conference for Bruker Corporation?

The BofA Securities 2021 Health Care Conference is on May 11, 2021, at 11:00 a.m. Eastern Time.

Who will present at the UBS Global Healthcare Virtual Conference for BRKR?

Frank Laukien and Mark Munch will present at the UBS Global Healthcare Virtual Conference on May 24, 2021.

How can I access the Jefferies Virtual Healthcare Conference by Bruker?

The Jefferies Virtual Healthcare Conference will be held on June 2, 2021, with live webcasts available on Bruker's Investor Relations website.

Where can I find the replays of Bruker's virtual conference presentations?

Replays of Bruker's virtual conference presentations will be available on their Investor Relations website for 30 days after each event.

What is Bruker Corporation's main focus?

Bruker Corporation specializes in high-performance scientific instruments and analytical solutions for life science and diagnostics.